nach oben

Administration and Policy in Mental Health and Mental Health Services Research

Erschienen in:

01.09.2006 | Original Paper

Intensive Case Management: A Critical Re-Appraisal of the Scientific Evidence for Effectiveness

verfasst von: Robert King

Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Intensive Case Management (ICM) is widely claimed to be an evidence-based and cost effective program for people with high levels of disability as a result of mental illness. However, the findings of recent randomized controlled trials comparing ICM with ‘usual services’ suggest that both clinical and cost effectiveness of ICM may be weakening. Possible reasons for this, including fidelity of implementation, researcher allegiance effects and changes in the wider service environment within which ICM is provided, are considered. The implications for service delivery and research are discussed.

Abbott, S., Smith, S., Clarke, R., Curson, C., De Souza Gomes, J., Heslop, K., Trainer, E., & Yellowlees, P. (1997). Who is a heavy service user? Preliminary development of a screening instrument for prospective consumers of a mobile intensive treatment team. Australian and New Zealand Journal of Psychiatry, 31, 744–750.PubMedCrossRef

Allness, D., & Knoedler, W. (2003). National program standards for ACT teams (2003 revision). NAMI, Arlington, VA, http://www.nami.org/Content/ContentGroups/Programs/PACT1/NationalStandardsforACTeams.pdf, (last accessed 11–16–04).

Bond, G. R., & Salyers, M. P. (2004). Prediction of outcome from the Dartmouth ACT Fidelity Scale. CNS Spectrums, 9, 937–942PubMed

Bond, G. R., Drake, R. E., Mueser, K. T., et al. (2001). Assertive community treatment for people with severe mental illness: Critical ingredients and impact on patients. Disease Management & Health Outcomes, 9, 141–159.CrossRef

Burgess, P., & Pirkis, J. (1999). The currency of case management: Benefits and costs. Current Opinion in Psychiatry, 12, 195–199.CrossRef

Burns, T. (2000). Models of community treatments in schizophrenia: do they travel? Acta Psychiatrica Scandinavica Supplementum, 407, 11–14.PubMedCrossRef

Burns, T., Creed, F., Fahy, T., Thompson, S., Tyrer, T., & White, I. (1999). Intensive versus standard case management for severe psychotic illness trial. UK700 Group. Lancet, 353, 2185–2189.PubMedCrossRef

Byford, S., Fiander, M., Torgerson, D., Barber, J, Thompson, S., Van Horn, E., Gilvarry, C., & Creed, F (2000). Cost-effectiveness of intensive v. standard case management for severe psychotic illness: UK700 case management trial. British Journal of Psychiatry, 176, 537–543.CrossRef

Chandler, D., Spicer, G. (2002). Capitated Assertive Community Treatment Program Savings: System Implications. Administration and Policy in Mental Health, 30, 3–19.PubMedCrossRef

Clarke G. N., Herinckx H. A., Kinney R. F., Paulson, R. I., Cutler, D. L., Lewis, K., & Oxman, E (2000). Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual care. Mental Health Services Research, 2, 155–164.PubMedCrossRef

Drake R. E., Mueser K. T., Torrey W. C., Miller, A. L, Lehman, A. F, Bond, G. R., Goldman, H. H., & Leff, H. S. (2000). Evidence-based treatment of schizophrenia. Current Psychiatry Reports, 2, 393–397.PubMedCrossRef

Dekker, J., Wijdenes, W., Koning, Y. A., Gardien, R., Hermandes-Willenborg, L., & Nusselder, H. (2002). Assertive community treatment in Amsterdam. Community Mental Health Journal, 38, 425–434.PubMedCrossRef

Duan, N., Braslow, J., Weisz, J., & Wells, K. (2001). Fidelity, adherence, and robustness of interventions. Psychiatric Services, 52, 413.PubMedCrossRef

Fiander, M., Burns, T., McHugo, G. J., & Drake, R. E. (2003). Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA. British Journal of Psychiatry, 182, 248–254.PubMedCrossRef

Ford, R., Barnes, A., Davies, R., Chalmers, C., Hardy, P., & Muijen, M. (2001). Maintaining contact with people with severe mental illness: 5-year follow-up of assertive outreach. Social Psychiatry & Psychiatric Epidemiology, 36, 444–447.CrossRef

Harrison-Read, P., Lucas, B., Tyrer, P., Ray, J., Shipley, K., Simmonds S., Knapp, M., Lowin, A., Patel, A., & Hickman M. (2002). Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London borough. Psychological Medicine, 32, 403–416.PubMedCrossRef

Harvey, K., Burns, T., Fiander, M., Huxley, P., Manley, C., & Fahy, T. (2002). The effect of intensive case management on the relatives of patients with severe mental illness. Psychiatric Services, 53, 1580–1585.PubMedCrossRef

Herdelin, A. C., & Scott, D. L. (1999). Experimental studies of the Program of Assertive Community Treatment (PACT). Journal of Disability Policy Studies, 10, 53–89.

Issakidis, C., Sanderson, K., Teesson, M., Johnston, S., & Buhrich, N. (1999). Intensive case management in Australia: a randomized controlled trial. Acta Psychiatrica Scandinavica, 99, 360–367.PubMedCrossRef

Johnston, S., Salkeld, G., Sanderson, K., Issakidis, C., Teesson, M., & Buhrich, N. (1998). Intensive case management: a cost-effectiveness analysis. Australian and New Zealand Journal of Psychiatry, 32, 551–559.PubMed

Latimer, E. A. (1999). Economic impacts of assertive community treatment: a review of the literature. Canadian Journal of Psychiatry, 44, 443–454.

Lehman, A. F., Dixon, L., Hoch, J. S., DeForge, B., Kernan, E., & Frank, R. (1999). Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness. British Journal of Psychiatry, 174, 346–352.PubMedCrossRef

Littell, J. H., Popa, M., & Forsythe, B. (2005). Multisystemic therapy for social, emotional, and behavioral problems in youth aged 10–17. Cochrane Database of Systematic Reviews, 19, CD004797.

Luborsky, L., Diguer, L., Seligman, D.A., Rosenthal, R., Krause, E.D., Johnson, S., Halperin, G., Bishop, M. Berman, J., & Schweitzer, E. (1999). The researcher’s own therapy allegiances: A “wild card” in comparisons of treatment efficacy. Clinical Psychology: Science & Practice, 6, 95–106.CrossRef

Marshall, M., & Lockwood, A. (1998). Assertive Community Treatment for People With Severe Mental Disorders (a Cochrane review). Oxford, England: Update Software (for the Cochrane Library).

Marshall, M., & Creed, F. (2000). Assertive community treatment—is it the future of community care in the UK? International Review of Psychiatry, 12, 191–196.CrossRef

McGrew, J. H., Bond, G. R., Dietzen, L. L., & Salyers, M. (1994). Measuring the fidelity of implementation of a mental health program model. Journal of Consulting and Clinical Psychology, 62, 670–678.PubMedCrossRef

McGrew, J. H., & Bond, G. R. (1995). Critical ingredients of assertive community treatment: Judgements of the experts. The Journal of Mental Health Administration, 22, 113–125.CrossRef

McHugo, G. J., Drake, R. E., Teague, G. B. & Xie, H. (1999). Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services, 50, 818–824.PubMed

Mowbray, C., Collins, M., Plum, T., Masterton, T., & Mulder R. (1997). Harbinger I: the development and evaluation of the first pact replication. Administration and Policy in Mental Health, 25,105–123.PubMedCrossRef

Mueser, K. T., Bond, G. R., Drake, R. E., & Resnick, S. G. (1998). Models of community care for severe mental illness: A review of research on case management. Schizophrenia Bulletin, 24, 37–74.PubMed

Rotheram-Borus. M. J., & Duan, N. J. (2003) Next generation of preventive interventions. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 518–526.PubMedCrossRef

Salkever, D., Domino, M. E., Burns B. J., Santos, A. B., Deci, P. A., Wagner, H. R., Faldowski, R. A., & Paolone, J. (1999). Assertive community treatment for people with severe mental illness: The effect on hospital use and costs. Health Services Research, 34, 577–601.PubMed

Salyers, M. P., Bond, G. R., Teague, G. B., Cox, J. F., Smith, M. E., Hicks, M. L., & Koop, J. I. (2003). Is it ACT yet? Real-world examples of evaluating the degree of implementation for assertive community treatment. Journal of Behavioral Health Services Research, 30, 304–320.PubMedCrossRef

Teague, G. B., Bond, G. R., & Drake, R. E. (1998). Program fidelity in assertive community treatment: development and use of a measure. American Journal of Orthopsychiatry, 68, 216–232.PubMedCrossRef

Stovall, J. (2001) Is Assertive Community Treatment ethical care? Harvard Review of Psychiatry, 9, 139–143.PubMed

Thase, M. (1999). What is the investigator allegiance effect and what should we do about it? Clinical Psychology: Science & Practice, 6, 113–115.CrossRef

Watson, J. C., Gordon, L. B., Stermac, L., Kalogerakos, F., & Steckley, P. (2003). Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. Journal of Consulting and Clinical Psychology, 71, 773–781.PubMedCrossRef

Ziguras, S., & Stuart, G. (2000). A meta-analysis of the effectiveness of mental health case management over 20 years. Psychiatric Services, 51, 1410–1421.PubMedCrossRef

Titel: Intensive Case Management: A Critical Re-Appraisal of the Scientific Evidence for Effectiveness
verfasst von: Robert King
Publikationsdatum: 01.09.2006
Verlag: Springer US
Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research / Ausgabe 5/2006
Print ISSN: 0894-587X
Elektronische ISSN: 1573-3289
DOI: https://doi.org/10.1007/s10488-006-0051-5

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2006

Cognitive and Clinical Predictors of Work Outcomes in Clients with Schizophrenia Receiving Supported Employment Services: 4-year Follow-Up

CATIE and the Value of Atypical Antipsychotics in the Context of Creating a Recovery-Oriented Behavioral Health System

Ethnicity and Clinical Psychiatric Diagnosis in Childhood

Beyond Criminalization: Toward a Criminologically Informed Framework for Mental Health Policy and Services Research

Service Utilization among Ethnic Minority Children with ADHD: A Model of Help-Seeking Behavior

In the Aftermath of CATIE: How Should Administrators Value Atypical Antipsychotic Medications?